Vous êtes sur la page 1sur 3

American College of Rheumatology Ad Hoc Committee. 1999.

Systemic lupus
erythematosus guidelines. Arthritis Rheum. 42(9): 785-96

Asherson R, Cervera R, De Groot P, Erkan D, Boffa MC, Pietta JC, et al. 2003.
Catastrophic antiphospholipid syndrome: international consensus statement on
classification criteria and treatment guidelines. Lupus. 12: 530-4

Bertsias G, Cervera R, Boumpas DT. 2012. Systemic Lupus Erythematous:


Pathogenesis and Clinical Features. Switzerland: Eular

Callen JP, Wortmann RL (2012). Dermatomyositis. Clinic in Dermatology 24: 363-


373.

Casals MR dkk (2015). Characterization of systemic disease in primary Sjögren's


syndrome: EULAR-SS Task Force recommendations for articular, cutaneous,
pulmonary and renal involvements. Rheumatology 54 (12): 2230-2238.

Clauw DJ. 2014. Fibromyalgia. JAMA. 311(15): 1547-55

Dhaliwal G. 2004. Hemolytic Anemia. American Family Physician. 69(11): 2599-606

Ewout dkk (2015). Prevalence of distal renal tubular acidosis in primary Sjögren's
syndrome. Rheumatology 54 (5): 933-939.

Gomes P, Joudzbaly G, Fernandes MH, Goubis Z (2012). Diagnostic approaches to


sjogren’s syndrome: a literature review and own clinical experience. Journal
of Oral & Maxillofacial Research, 3 (1): 1-13

Hahn BH. 2012. Systemic Lupus Erythematosus. Dalam: Longo DL, Kasper DL,
Jameson JL, Fauci AS, Hauser SL, Loscalzo J. Harrisons Principles of Interna
Medicine 18th Edition. USA: The McGraw Hill Companies, hal 2677-84

Hariyanto A. 2011. Kriteria diagnostic vaskulitis. CDK. 38(7): 495-6

Isbagio H, Kasjmin YI, Setyohadi B, et al. 2009. Lupus Eritematosus Sistemik.


Dalam: Sudoyo AW, Setyohadi,B, Alwi I (eds). Ilmu Penyakit Dalam Jilid III
Edisi Kelima. Jakarta: Interna publishing, hal: 2565-27579

Isbagio H. 2014. Lupus Eritematous Sistemik. Dalam: Tano C, Liwang F, Hanifan S,


Pradipta EA (eds). Kapita Selekta Kedokteran. Jakarta: Media Aesculapius,
hal: 842-845

James dkk (2016). Sjogren Syndrome: A Review on Diagnostic Methods and


Treatment Strategies. World Journal of Pharmaceutical Sciences.
Kruszka P, O’brian RJ (2009). Diagnosis and Management of Sjögren Syndrome.
American Academy of Family Physicians.

Lam C, Vleugels RA (2012). Management of cutaneius dermatonyositis.


Dermatologic Therapy 10 (1):1529-1532.

Lechner K, Jager U. 2010. How I treat autoimmune hemolytic anemias in adults. The
American Society of Hematology. 116(11): 1831-1838

Lehner GF, Brunner-Palka M, Rettenbacher T, Schmidauer R, Herold M (2014).


Maintenance of rituximab treatment in a patient with primary Sjögren’s
syndrome. Rheumatology 53 (7): 1349-1350

Luzzato L. 2012. Hemolytic Anemias and Anemia Due to Acute Blood Loss. In:
Kasper D, Fauci A, Hauser S, Longo D, Jameson JL, Loscalzo J. 2010.
Harrison’s Principle of Internal Medicine 18th edition. United States of
America: Mcgraw Hill

Mammen AL (2012). Dermatomyositis and polymyositis Clinical presentation,


autoantibodies, and pathogenesis. Annals of The New York Academy OF
Sciences. 134-153

Packman CH. 2015. The clinical pictures of autoimmune hemolytic anemia. The
American Society of Hematology. 42(5):317-24

Parjono E, Hariadi K. 2010. Anemia Hemolitik Autoimun. Dalam: Suyono S,


Waspadji S, Lesmana L, Alwi I, Setiati S, Sundaru H, dkk. 2010. Buku Ajar
Ilmu Penyakit Dalam. Jilid II. Edisi V. Jakarta: interna Publishing, hal: 1152-
1156

Przybylski1 G, Jarzemska1 A, Czerniak J, Siemiątkowska K, Gadzińska A, Cieśliński


K (2013). A case report of a patient with dermatomyositis as a prodromal sign
of lung cancer. Regional Center of Pulmonology, Bydgoszcz, Poland 118 (3):
143-147

Rasmussen dkk (2016). Previous diagnosis of Sjögren’s Syndrome as rheumatoid


arthritis or systemic lupus erythematosus. Rheumatology 55 (7): 1195-1201

Jacobus DJ (2014). Diagnosis dan Manajemen Sindrom Sjogren. CDK-216 41 (5):


336-341.

Sada PR, Isenberg D, Ciurtin C (2015). Biologic treatment in Sjögren's syndrome.


Rheumatology. 54 (2): 219-230

Silva et al (2009). Juvenile dermatomyositis (JDM) and severe pulmonary


involvement: case report. Rheumatoid 49(4): 462-467
Singh AG, Singh L, Matteson (2016). Rate, risk factors and causes of mortality in
patients with Sjögren’s syndrome: a systematic review and meta-analysis of
cohort studies. Rheumatology 55 (3): 450-460

Soyfoo M, Cogan E (2012). Diagnostic and Prognostic Features of Sjögren’s


Syndrome. Departments of Rheumatology Internal Medicine Erasme Hospital,
Université Libre de Bruxelles, Belgium.

Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, et al.


(2014). Clinical practice guideline on diagnosis and treatment of
hyponatremia. European Journal of Endocrinology

Thompson N, Isenberg DA, Jury EC, Ciurtin C (2016). Exploring BAFF: its
expression, receptors and contribution to the immunopathogenesis of
Sjögren’s syndrome. Rheumatology 55 (9): 1547-1555

thelupussuportnetwork.org [diakses 30 Oktober 2016]

Tjokorda RP. 2006. Hiperurisemia. Dalam: Sudoyo AW et al (ed). Buku Ajar Ilmu
Penyakit Dalam Jilid II edisi IV. Jakarta: Pusat Penerbitan Departemen Ilmu
Penyakit Dalam FKUI, hal 1213-7

Yuliasih (2009). Sindrom Sjogren. Ilmu Penyakit Dalam Jilid III Edisi V. Jakarta:
Internapublishing. Pg 2514-2518.